Clinical Pharmacology & Therapeutics · 2018 · 26 citations · 2 references
MedicinePediatricsPharmacotherapyChild PsychiatryPsychopharmacologySubstance Use DisordersAttention DisordersAttention-deficit/hyperactivity DisorderChild PsychopharmacologyNeurodevelopmental DisordersPsychopharmacology In ChildrenStimulant TherapyAdhd PharmacotherapyAdhd TreatmentAdolescent AdhdCochrane Review MethodologyMethylphenidate PharmacologyMethylphenidate TherapyPediatric Stimulant MedicationsPractice Evidence
Much remains unclear about the benefits and harms of methylphenidate for children and adolescents with attention-deficit/hyperactivity disorder (ADHD). Between 2012 and 2018, we conducted two Cochrane systematic reviews on methylphenidate for ADHD. This article explores the main findings in relation to evidence-based practice and our current understanding of ADHD.
2